Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Management targets EBITDA breakeven by Q4 FY27 despite elevated marketing costs and temporary margin pressure.
Zota Health Care Ltd (NSE:ZOTA) reports a remarkable 98.2% YoY revenue increase, driven by strategic store expansions and robust customer engagement.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.